OTC Stock Splits

[Rager]

PMCL - Pharm Control Shareholder Update
May 11, 2007 9:45:00 AM
NEW YORK, NY -- (MARKET WIRE) -- 05/11/07 -- The Board of Directors of Pharm Control Ltd. (PINKSHEETS: PMCL) is proud to announce that they have decided to reward patient shareholders with a forward stock split whereby shareholders of record on June 29, 2007 will receive eight (8) new shares for every five (5) shares they hold.

The company intends to proceed with the previously announced stock spin-off of the European distribution company after this dividend is completed.

Pharm Control Ltd. is still in the process of completing its change of transfer agents while awaiting the approval of the new stock symbol by the NASD.

About Pharm Control Ltd.

Pharm Control Ltd. is a leading medicine Research and Development company that is devoted to developing medicines that allow patients to live longer, healthier, and more productive lives. The Company's founders have invested over 10 years of research discovering and developing new and effective non-synthetic medicines to fight disorders and sickness in the modern world.

Safe Harbor Statement

The preceding includes forward-looking statements, which involve known and unknown risks, and uncertainties, which may cause the company's actual results in future periods to differ materially from forecasted results. Any forward-looking statements above are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Actual results may differ materially due to a variety of factors, including, without limitation, competition, intellectual property rights, litigation, needs of liquidity, and other risks detailed from time to time in the company's reports filed with the SEC. Investors are cautioned that such forward-looking statements involve risks and uncertainties, including, but not limited to, continued acceptance of the company's products and services, competition, new products and technological changes, as well as any and all "other risks" associated with business.

Contact:

Pharm Control Ltd.
Eugene Kron
Vice President
Email: [e-mail]
Tel: [phone]